Three Mutations in the Stalk Region of Hemagglutinin Affect the pH of Fusion and Pathogenicity of H5N1 Influenza Virus


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Previously, an attenuated variant Ku/at was obtained from the highly pathogenic avian influenza virus A/chicken/Kurgan/3/2005 (H5N1) by a reverse selection method aimed at increasing the virus resistance to a proteolytic cleavage and acidic pH values. In the Ku/at, 10 mutations in proteins PB2, PB1, HA, NA, and NS1 occurred. In comparison with the parental strain, the pH of the conformational transition of the viral glycoprotein hemagglutinin (HA) and virulence for mice and chickens have decreased in an attenuated variant. The purpose of this work is to clarify the role of three mutations in the stalk region of HA: Asp54Asn in HA1 and Val48Ile and Lys131Thr in HA2 (H3 HA numbering). To attain these ends, analogous substitutions were introduced into HA with a deleted polybasic cleavage site (important for pathogenicity) of the recombinant A/Vietnam/1203/04-PR8/CDC-RG (H5N1) virus, and so we created the VN3x-PR variant. Viruses VN3x-PR and Ku/at with the same three mutations, but different proteolytic cleavage sites in HA, as well as the corresponding initial viruses, were tested for pathogenicity in mice and in the erythrocyte hemolysis test. Compared with the parental strains, the virulence of their mutant variants in the case of intranasal infection of BALB/c mice decreased by 4–5 orders of magnitude, and the pH of the conformational transition of HA decreased from 5.70–5.80 to 5.25–5.30, which is typical for low pathogenic natural isolates. Thus, as a result of the study, the attenuating role of these three mutations in HA has been proved, a correlation was established between the pH value of the HA conformational transition and the virulence of H5N1 influenza viruses, and it was shown that the polybasic cleavage site of the H5 HA does not always determine high pathogenicity of the virus.

About the authors

N. F. Lomakina

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products,
Russian Academy of Sciences; N.F. Gamaleya National Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Author for correspondence.
Email: nflomakina@yandex.ru
Russian Federation, Moscow, 108819; Moscow, 123098

G. K. Sadykova

N.F. Gamaleya National Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: nflomakina@yandex.ru
Russian Federation, Moscow, 123098

T. A. Timofeeva

N.F. Gamaleya National Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: nflomakina@yandex.ru
Russian Federation, Moscow, 123098

I. A. Rudneva

N.F. Gamaleya National Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: nflomakina@yandex.ru
Russian Federation, Moscow, 123098

E. Yu. Boravleva

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products,
Russian Academy of Sciences

Email: nflomakina@yandex.ru
Russian Federation, Moscow, 108819

P. A. Ivanov

N.F. Gamaleya National Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation; The Mental Health Research Center

Email: nflomakina@yandex.ru
Russian Federation, Moscow, 123098; Moscow, 115522

A. G. Prilipov

N.F. Gamaleya National Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: nflomakina@yandex.ru
Russian Federation, Moscow, 123098

A. S. Gambaryan

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products,
Russian Academy of Sciences

Email: nflomakina@yandex.ru
Russian Federation, Moscow, 108819

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Pleiades Publishing, Inc.